218 related articles for article (PubMed ID: 33109536)
1. Potential for Treatment of Glioblastoma: New Aspects of Superparamagnetic Iron Oxide Nanoparticles.
Marekova D; Turnovcova K; Sursal TH; Gandhi CD; Jendelova P; Jhanwar-Uniyal M
Anticancer Res; 2020 Nov; 40(11):5989-5994. PubMed ID: 33109536
[TBL] [Abstract][Full Text] [Related]
2. Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs).
Shevtsov M; Nikolaev B; Marchenko Y; Yakovleva L; Skvortsov N; Mazur A; Tolstoy P; Ryzhov V; Multhoff G
Int J Nanomedicine; 2018; 13():1471-1482. PubMed ID: 29559776
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyapatite as a Vehicle for the Selective Effect of Superparamagnetic Iron Oxide Nanoparticles against Human Glioblastoma Cells.
Pernal S; Wu VM; Uskoković V
ACS Appl Mater Interfaces; 2017 Nov; 9(45):39283-39302. PubMed ID: 29058880
[TBL] [Abstract][Full Text] [Related]
4. Dual-targeting and excretable ultrasmall SPIONs for T
Du C; Liu X; Hu H; Li H; Yu L; Geng D; Chen Y; Zhang J
J Mater Chem B; 2020 Mar; 8(11):2296-2306. PubMed ID: 32100784
[TBL] [Abstract][Full Text] [Related]
5. Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme.
Sun L; Joh DY; Al-Zaki A; Stangl M; Murty S; Davis JJ; Baumann BC; Alonso-Basanta M; Kaol GD; Tsourkas A; Dorsey JF
J Biomed Nanotechnol; 2016 Feb; 12(2):347-56. PubMed ID: 27305768
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
[TBL] [Abstract][Full Text] [Related]
7. Ionizing radiation improves glioma-specific targeting of superparamagnetic iron oxide nanoparticles conjugated with cmHsp70.1 monoclonal antibodies (SPION-cmHsp70.1).
Shevtsov MA; Nikolaev BP; Ryzhov VA; Yakovleva LY; Marchenko YY; Parr MA; Rolich VI; Mikhrina AL; Dobrodumov AV; Pitkin E; Multhoff G
Nanoscale; 2015 Dec; 7(48):20652-64. PubMed ID: 26599206
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model.
Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF
Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427
[TBL] [Abstract][Full Text] [Related]
9. Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors.
Shevtsov MA; Nikolaev BP; Yakovleva LY; Marchenko YY; Dobrodumov AV; Mikhrina AL; Martynova MG; Bystrova OA; Yakovenko IV; Ischenko AM
Int J Nanomedicine; 2014; 9():273-87. PubMed ID: 24421639
[TBL] [Abstract][Full Text] [Related]
10. pH-responsive pHLIP (pH low insertion peptide) nanoclusters of superparamagnetic iron oxide nanoparticles as a tumor-selective MRI contrast agent.
Wei Y; Liao R; Mahmood AA; Xu H; Zhou Q
Acta Biomater; 2017 Jun; 55():194-203. PubMed ID: 28363789
[TBL] [Abstract][Full Text] [Related]
11. Recombinant interleukin-1 receptor antagonist conjugated to superparamagnetic iron oxide nanoparticles for theranostic targeting of experimental glioblastoma.
Shevtsov MA; Nikolaev BP; Yakovleva LY; Dobrodumov AV; Zhakhov AV; Mikhrina AL; Pitkin E; Parr MA; Rolich VI; Simbircev AS; Ischenko AM
Neoplasia; 2015 Jan; 17(1):32-42. PubMed ID: 25622897
[TBL] [Abstract][Full Text] [Related]
12. Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles.
Tefft BJ; Uthamaraj S; Harburn JJ; Klabusay M; Dragomir-Daescu D; Sandhu GS
J Vis Exp; 2015 Oct; (105):e53099. PubMed ID: 26554870
[TBL] [Abstract][Full Text] [Related]
13. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.
Wahajuddin ; Arora S
Int J Nanomedicine; 2012; 7():3445-71. PubMed ID: 22848170
[TBL] [Abstract][Full Text] [Related]
14. Preparation of superparamagnetic iron oxide/doxorubicin loaded chitosan nanoparticles as a promising glioblastoma theranostic tool.
Gholami L; Tafaghodi M; Abbasi B; Daroudi M; Kazemi Oskuee R
J Cell Physiol; 2019 Feb; 234(2):1547-1559. PubMed ID: 30145790
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Efficiency of Multiple Applications of Magnetic Hyperthermia Technique in Glioblastoma Using Aminosilane Coated Iron Oxide Nanoparticles: In Vitro and In Vivo Study.
Rego GNA; Nucci MP; Mamani JB; Oliveira FA; Marti LC; Filgueiras IS; Ferreira JM; Real CC; Faria DP; Espinha PL; Fantacini DMC; Souza LEB; Covas DT; Buchpiguel CA; Gamarra LF
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023985
[TBL] [Abstract][Full Text] [Related]
16. Clustering superparamagnetic iron oxide nanoparticles produces organ-targeted high-contrast magnetic resonance images.
Hobson NJ; Weng X; Siow B; Veiga C; Ashford M; Thanh NT; Schätzlein AG; Uchegbu IF
Nanomedicine (Lond); 2019 May; 14(9):1135-1152. PubMed ID: 31050589
[No Abstract] [Full Text] [Related]
17. Brain and bone cancer targeting by a ferrofluid composed of superparamagnetic iron-oxide/silica/carbon nanoparticles (earthicles).
Wu VM; Huynh E; Tang S; Uskoković V
Acta Biomater; 2019 Apr; 88():422-447. PubMed ID: 30711662
[TBL] [Abstract][Full Text] [Related]
18. Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations.
Shirvalilou S; Khoei S; Khoee S; Raoufi NJ; Karimi MR; Shakeri-Zadeh A
Chem Biol Interact; 2018 Nov; 295():97-108. PubMed ID: 30170108
[TBL] [Abstract][Full Text] [Related]
19. Magnetic targeting combined with active targeting of dual-ligand iron oxide nanoprobes to promote the penetration depth in tumors for effective magnetic resonance imaging and hyperthermia.
Chen L; Wu Y; Wu H; Li J; Xie J; Zang F; Ma M; Gu N; Zhang Y
Acta Biomater; 2019 Sep; 96():491-504. PubMed ID: 31302299
[TBL] [Abstract][Full Text] [Related]
20. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.
Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP
Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]